(Alliance News) - AstraZeneca PLC on Sunday said its rescue medication candidate PTO27 showed positive results in its Mandala Phase III trial. Read More
(AllianceNews) - NetScientific PLC on Monday said its subsidiary ProAxsis Ltd had successfully completed the development and evaluation of an AstraZeneca PLC Covid-19 antibody test with "impressive" results. Read More
(Alliance News) - AstraZeneca PLC on Thursday reported several positive developments in its pipeline, including its breast cancer drug clearing another regulatory hurdle, and positive phase III trial results for Farxiga and Ultomiris. Read More
(Alliance News) - AstraZeneca PLC on Wednesday said its checkpoint inhibitor drug Imfinzi, generically durvalumab, has been granted priority review by the US Food & Drug Administration. Read More
(Alliance News) - JD Wetherspoon on Wednesday said sales improved steadily since the ending of all Covid restrictions, but the pub chain said virus woes have been replaced by "considerable pressure on costs" as a new source of concern. Read More
(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed. Read More
(Alliance News) - AstraZeneca PLC on Friday reported a sharp rise in first-quarter revenue, though profit declined, and the drugmaker also announced plans for a new strategic site in the US. Read More
(Alliance News) - Stock prices in London are seen opening higher on Friday, making a confident end to a tricky month for markets, which have faced Covid-19 worries in China, alongside rampant inflation and central bank monetary tightening in response. Read More
(Alliance News) - AstraZeneca PLC on Thursday said its drug Ultomiris has been approved by the US Food & Drug Administration for the treatment of adults with generalised myasthenia gravis. Read More
(Alliance News) - AstraZeneca PLC on Wednesday said a cancer drug it has helped develop to treat a form of breast cancer has been granted breakthrough therapy designation in the US. Read More
(Alliance News) - AstraZeneca PLC on Monday announced its candidate for unresectable liver cancer Tremelimumab has been accepted under priority review by the US Food & Drug Administration. Read More
(Alliance News) - Stock prices in Europe are seen opening lower on Monday, with a grim Covid-19 situation in China adding to a mountain of worries for equities investors, which included hawkish comments made by Federal Reserve Chair Jerome Powell late last week. Read More
(Alliance News) - AstraZeneca PLC late Wednesday said a clinical trial found its Evusheld antibody therapy markedly reduced the risk of developing symptomatic Covid-19. Read More
(Alliance News) - Oxford BioMedica PLC on Wednesday warned it will swing to a loss in 2022 and revenue will fall as Covid-19 vaccine manufacturing for AstraZeneca PLC will take a pause. Read More
(Alliance News) - AstraZeneca PLC on Tuesday said its lung cancer antibody drug conjugate Enhertu has received priority review from the Food & Drug Administration in the US. Read More
(Alliance News) - Stock trading in London is set for a downbeat return following the long Easter weekend, with traders mulling global growth prospects. Read More
